has been no bed of roses. From the inception in 1958‚ it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd.‚ the flagship company‚ is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and
Premium Pharmaceutical industry Pharmacology Limited company
Marketing Strategy Use of strategy frameworks to analyse competitive dynamics in the pharmaceutical industry Graham Leask is a member of the Economics and Strategy Group at Aston University‚ where he currently teaches Value Based Strategy and Entrepreneurial Strategy to final year and postgraduate students. Graham joined ICI Agrochemicals Research‚ before entering the pharmaceutical industry‚ where he worked in marketing and general management roles for several top ten pharmaceutical companies.
Premium Strategic management Michael Porter Marketing plan
growth of the industry growth at times. |Years |1999 | |Square Pharmaceuticals Limited |20.06 | |Incepta Pharmaceuticals Limited |7.53 | |Beximco Pharmaceuticals Limited |7.09 | |The Acme Laboratories Limited |5.25 | |Eskayef Pharmaceuticals Limited |4.64 | |ACI Limited |4.52 | |Opsonin Chemical Industries Limited
Premium Financial ratios Financial ratio Revenue
constantly replenish the supply of potential blockbusters requires a consistent and dedicated approach to drug R&D. However no longer is inhouse research expertise sufficient. 2 Chart 1 Decreased R&D Productivity (source: FDA - PhRMA 2007) Pharma R&D Investments (Billion USD) 120 New medicines Approved by FDA 60 100 50 80 40 60 30 40 20 20 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 YEAR 0 To fill this pipeline gap‚ pharmaceutical
Premium Net present value Discounted cash flow Cash flow
Q4 - OE_Strengths What do you see as Flowers’ particular strengths? "Barriers to entry to their business. Their moats are wide." Q5 - OE_Weaknesses What do you see as Flowers’ particular weaknesses? "To me it’s a hard thing to understand. It’s difficult for investors to understand the value of the company. Maybe it’s confusing for investors. It seems like it would be pretty straightforward but if there’s more volatility in the business than you’d expect‚ or maybe that investors don’t understand
Premium Investment Coca-Cola Finance
...............................................................................3 Short description of the company .......................................................................4 Characteristics of the supply chain and logistics in pharma.................................5 Downstream supply chain in pharmaceuticals ..................................................7 Particularities of SCM in pharmaceutical field ................................................8 Supply to stock
Premium Logistics Supply chain management Supply chain
Creating value‚ driving growth 3 7 th A N N U A L R E P O R T 2 0 0 9 - 2 0 1 0 37th ANNUAL REPORT 2009-10 Torrent Pharmaceuticals Limited 2 N TE CO N TS Corporate Information 02 Notice 03 Directors’ Report 06 Report on Corporate Governance 14 Auditors’ Report 24 Audited Financial Statements 28 Management Discussion and Analysis 55 Consolidated Financial Statements 66 37th ANNUAL REPORT 2009-10 3 CORPORATE INFORMATION DIRECTORS Sudhir Mehta Chairman REGISTERED
Premium Board of directors Corporate governance
PHARMA-SAYA INNOVATIVE SOLUTIONS‚ INC. Bringing better smiles that build better lives 259 CEU Bldg.‚ Sen. Gil Puyat Ave.‚ Makati City Phils. OUR MOTTO Bringing better smiles that build better lives. OUR MISSION-VISION STATEMENT PSIS is a Philippine company that values one of the most cognizant traits of the Filipino men‚ being gleeful‚ where the connotation that the SMILE is the most powerful weapon and shield of the Filipino started. The company is dedicated to bring better
Free Metro Manila Manila Toothpaste
Government of Western Australia Public Sector Commission LEArnInG froM LEAvInG A guide to Exit Interviews for the Western Australian Public Sector. Copyright © 2009 by the Public Sector Commission The Commission has no objection to this document being copied‚ in whole or in part‚ provided there is due acknowledgement of any material quoted from this document. Copies of this document are available in alternative formats upon request. Public Sector Commission 197 St Georges Terrace‚ Perth WA
Premium Interview Employment Exit interview
1) Millenniums Pharmaceuticals strategy basically focused on revolutionizing drug development through the use of new technology during growth phase and making organizational changes during its maturing phase of by making strategic improvements in the organizational structure‚ making alliances‚ outsourcing etc by having vertical integration and moving from upstream to downstream model. In phase 1‚ technology helped the firm leapfrog most other biotechnology firms in the early stage of drug target
Premium Strategic management